Zion Market Research has published a new report titled “Varicose Vein Treatment Market by Procedure (Injection Sclerotherapy, Endovenous Ablation and Surgical Ligation/Stripping), and Product (Ablation Devices, Radiofrequency Ablation Devices, Laser Ablation Devices, and Venous Closure Products): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025”.
According to the report, global demand for Varicose Vein Treatment Market was valued at approximately USD 1237.8 Million in 2018, and is expected to generate revenue of around USD 1788.4 Million by end of 2025, growing at a CAGR of around 5.48 % between 2018 and 2025.
Varicose veins are voluminous, puffy veins that often occur on the legs and feet. Those occur when the valves in the veins do not function properly, because blood does not flow efficiently. For health reasons, the veins rarely require care, but treatment is available for swollen, sore knees, and if there is significant discomfort. If the patient has no symptoms of discomfort and it doesn’t bother to see the varicose veins, treatment may not be needed. However, where symptoms may occur, treatment may be taken to alleviate pain or discomfort, overcome complications such as leg ulcers, skin discoloration, or swelling.
Request Free Sample is Available @ https://www.zionmarketresearch.com/sample/varicose-vein-treatment-market
Elderly people have a greater chance of developing varicose veins. The effect of aging on the structure and functions of the vein is found to be important. Varicose vein affects one person in two over 50 years of age. The occurrence of this disease is also normal for overweight people and pregnant women. Some of the therapies on the market are sclerotherapy, laser therapy, and radiofrequency ablation. Sclerotherapy is used as a first-line treatment for varicose, spider and reticular veins. In the near future, major changes are expected to occur in surgical procedures for varicose veins. Surgery has been largely replaced by non-invasive alternatives. Non-invasive approaches often require a reduction in hospital stays and the risk of infection, thus saving time and cost. Most surgeons adopt foam sclerotherapy, endovenous laser treatment, and radiofrequency ablation as opposed to traditional surgical procedures.
The market for Varicose Vein Treatment is segmented based on procedure, product and region. Based on procedure, the market is segmented into Injection Sclerotherapy, Endovenous Ablation, and Surgical Ligation/Stripping. Sclerotherapy is a non-invasive technique involving the injection into the veins of a foam sclerosant. It’s less painful because it doesn’t involve vein cutting. Patient healing is quicker as it does not require admission to the hospital.
Based on the Product, the market is bifurcated Ablation Devices, Radiofrequency Ablation Devices, Laser Ablation Devices and Venous Closure Products. Over the forecast period, the endovenous ablation segment is likely to see the fastest growth. As the procedure is minimally invasive and associated with fewer complications, the endovenous ablation technique is favoured over traditional procedures such as surgical stripping and ligation.
Geographically, the market is into the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further classification into key countries. North America led the market in 2018 as it has an aesthetically conscious large population base in terms of revenue share. People are willing to undergo cosmetic procedures because of the obvious results and safety. North America is an early adopter of technology and the evidence of safety and efficacy in laser treatment has helped to reduce the stigma associated with cosmetic procedures and has helped to gain social acceptance for laser procedures, particularly by men. Asia Pacific is expected to be the fastest growing segment in the coming years due to the presence of a significant elderly population, increased disposable income, and increased awareness of these procedures. The market is highly competitive due to various regulatory factors, resulting in the disparity in the availability of goods in different countries.
Some of the players included in Varicose Vein Treatment market are AngioDynamics, Inc., Medtronic plc, Syneron Medical Ltd., Biolitec AG, Lumenis Ltd., Energist Group, Eufoton srl, Quanta Systems S.p.A. and Teleflex, Inc amongst others.
The report segments global Varicose Vein Treatment market as follows:
Global Varicose Vein Treatment Market: Procedure Segment Analysis
Global Varicose Vein Treatment Market: Product Segment Analysis
Global Varicose Vein Treatment Market: Regional Segment Analysis
To view TOC of this report is available upon request @ https://www.zionmarketresearch.com/toc/varicose-vein-treatment-market